We examined the level of p53 expression in cancer patient samples used in Figure 5, and we determined FOXO3 and RRM2B expression levels in patient samples that exhibited strong p53 staining in IHC assays, which is often considered to indicate p53 mutation or deficiency. The gene discussed is FOXO3; the disease is cancer.